newsfilter
← Latest News
Business Wire·

AN2 Therapeutics to Participate in Fireside Chat at Leerink Global Healthcare Conference

  • AN2 Therapeutics, Inc. (NASDAQ: ANTX) announced its Co-Founder, Chairman, President, & CEO Eric Easom will attend a fireside chat at the Leerink Global Healthcare Conference.
  • The event is scheduled for March 10, 2026, at 3:40 PM ET.
  • A webcast will be accessible via the Investors section of the company website at www.an2therapeutics.com.
  • An archived replay of the presentation will be available for at least 30 days following the event.
  • AN2 Therapeutics is developing small molecule therapeutics based on its boron chemistry platform for Chagas disease, NTM lung disease caused by M. abscessus, melioidosis, oncology, & infectious diseases.
  • Company contacts include CFO Lucy O. Day for company inquiries, ir@an2therapeutics.com for investor relations, & Anne Bowdidge for media inquiries.